Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;25(2):247-54.
doi: 10.1097/MOP.0b013e32835e1eb6.

Phthalate exposure and children's health

Joseph M Braun  1 , Sheela Sathyanarayana, Russ Hauser
Affiliations
Review

Phthalate exposure and children's health

Joseph M Braun et al. Curr Opin Pediatr. 2013 Apr.

Abstract

Purpose of review: Phthalates are multifunctional chemicals used in personal care products, medications, and plastics. We reviewed the epidemiological literature examining the relationship between early life phthalate exposure and pediatric health outcomes.

Recent findings: Five studies from Asia, Europe, and the United States suggest that childhood exposure to di-2-ethylhexyl phthalate (DEHP) and butylbenzyl phthalate (BBzP) may increase the risk of allergic diseases including asthma and eczema. Six studies from four different prospective cohorts report that gestational BBzP, DEHP, di-butyl phthalate (DBP), and di-ethyl phthalate (DEP) exposures are associated with alterations in infant/toddler physical development as well as parent-reported externalizing, internalizing, and autistic-like child behavior. However, there are inconsistencies related to the specific phthalates and behavioral domains. Two small studies report shorter anogenital distance among male infants with higher gestational phthalate exposure.

Summary: Several epidemiological studies suggest fetal and childhood exposure to some phthalates may perturb normal development, with several studies consistently reporting increased risk of allergic diseases with DEHP and BBzP exposure. Although anticipatory guidance is not evidence-based at this time, providers can counsel concerned patients to reduce phthalate exposures in order to protect the developing fetus and child from potential adverse health outcomes.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts of interest.

References

    1. Teitelbaum SL, Britton JA, Calafat AM, Ye X, Silva MJ, Reidy JA, Galvez MP, Brenner BL, Wolff MS. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the united states. Environmental research. 2008;106(2):257–269. - PubMed
    1. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, Brock JW, Needham LL, Calafat AM. Urinary levels of seven phthalate metabolites in the u.S. Population from the national health and nutrition examination survey (nhanes) 1999–2000. Environmental health perspectives. 2004;112(3):331–338. - PMC - PubMed
    1. Becker K, Goen T, Seiwert M, Conrad A, Pick-Fuss H, Muller J, Wittassek M, Schulz C, Kolossa-Gehring M. Geres iv: Phthalate metabolites and bisphenol a in urine of german children. International journal of hygiene and environmental health. 2009;212(6):685–692. - PubMed
    1. Koo HJ, Lee BM. Estimated exposure to phthalates in cosmetics and risk assessment. Journal of toxicology and environmental health. 2004;67(23–24):1901–1914. - PubMed
    1. Hubinger JC. A survey of phthalate esters in consumer cosmetic products. Journal of cosmetic science. 2010;61(6):457–465. - PubMed

Publication types

MeSH terms